Basics Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Instruments and Equipment Market Cap: $4.56B Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 2.03% Avg Daily Range (30 D): $1.93 | 2.26% Avg Daily Range (90 D): $1.64 | 1.80% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .8M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 48 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 5,778 Avg Inst. Trade: $2.96M Avg Inst. Trade (30 D): $4.44M Avg Inst. Trade (90 D): $5.42M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.2M Avg Closing Trade (30 D): $10.28M Avg Closing Trade (90 D): $11.6M Avg Closing Volume: 59.38K     News Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.64 $-.34 $-.32 Diluted EPS $-1.64 $-.34 $-.32 Revenue $ 432.95M $ 124.12M $ 106.66M Gross Profit $ 330.52M $ 97.22M $ 82.35M Net Income / Loss $ -92.79M $ -19.66M $ -18.15M Operating Income / Loss $ -96.69M $ -22.69M $ -20.68M Cost of Revenue $ 102.43M $ 26.9M $ 24.32M Net Cash Flow $ 37.98M $ -11.56M $ -53.52M PE Ratio